Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
4 "Kyung Chul Moon"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Genitourinary cancer
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations
Boram Song, Seok Hyun Lee, Jeong Hwan Park, Kyung Chul Moon
Cancer Res Treat. 2024;56(1):280-293.   Published online September 11, 2023
DOI: https://doi.org/10.4143/crt.2023.577
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study aimed to evaluate the molecular features of clear cell adenocarcinoma (CCA) of the urinary tract and investigate its pathogenic pathways and possible actionable targets.
Materials and Methods
We retrospectively collected the data of patients with CCA between January 1999 and December 2016; the data were independently reviewed by two pathologists. We selected five cases of urinary CCA, based on the clinicopathological features. We analyzed these five cases by whole exome sequencing (WES) and subsequent bioinformatics analyses to determine the mutational spectrum and possible pathogenic pathways.
Results
All patients were female with a median age of 62 years. All tumors were located in the urethra and showed aggressive behavior with disease progression. WES revealed several genetic alterations, including driver gene mutations (AMER1, ARID1A, CHD4, KMT2D, KRAS, PBRM1, and PIK3R1) and mutations in other important genes with tumor-suppressive and oncogenic roles (CSMD3, KEAP1, SMARCA4, and CACNA1D). We suggest putative pathogenic pathways (chromatin remodeling pathway, mitogen-activated protein kinase signaling pathway, phosphoinositide 3-kinase/AKT/mammalian target of rapamycin pathway, and Wnt/β-catenin pathway) as candidates for targeted therapies.
Conclusion
Our findings shed light on the molecular background of this extremely rare tumor with poor prognosis and can help improve treatment options.

Citations

Citations to this article as recorded by  
  • Urethral clear cell adenocarcinoma in an adult female: A rare case report
    Yacob Sheiferawe Seman, Michael Teklehaimanot Abera, Fadil Nuredin Abrar, Tesfaye Kebede Legesse, Mesfin Asefa Tola, Tsiyon Nigusie Alemu
    Urology Case Reports.2025; 58: 102882.     CrossRef
  • Two rare cases of primary clear cell adenocarcinoma of the urethra: clinical experience, case report and literature review
    Bohao Jiang, Jiyuan Hu, Benqiao Wang, Xujia Liu, Ling Tong, Yitong Xu, Hao Zhang
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • Association between CACNA1D polymorphisms and hypospadias in a southern Chinese population
    Ye He, Binyao Li, Xinying Zhao, Lingling Pan, Yanqing Liu, Chaoting Lan, Fuming Deng, Wen Fu, Yan Zhang, Xiaoyu Zuo
    Journal of Pediatric Urology.2024; 20(3): 438.e1.     CrossRef
  • The L‐type calcium channel CaV1.3: A potential target for cancer therapy
    Xuerun Liu, Boqiang Shen, Jingyi Zhou, Juan Hao, Jianliu Wang
    Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
  • 4,345 View
  • 201 Download
  • 5 Web of Science
  • 4 Crossref
Close layer
Sarcoma
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim
Cancer Res Treat. 2021;53(4):1195-1203.   Published online February 1, 2021
DOI: https://doi.org/10.4143/crt.2020.1337
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Angiosarcoma is a highly aggressive mesenchymal tumor. Although systemic chemotherapy is often considered for the inoperable or metastatic angiosarcoma, the outcome of such treatment is unsatisfactory and poorly delineated.
Materials and Methods
We reviewed electronic medical records of 75 patients with angiosarcoma who were treated with systemic chemotherapy for inoperable or metastatic disease. Patients were classified as having liver involvement if they had either primary or metastatic hepatic lesions.
Results
Among the patients evaluated, 51 patients were male (68%) and 24 patients (32%) had primary cutaneous angiosarcoma. Liver involvement was present in 28 patients (37.3%). A total of 59 patients received first-line weekly paclitaxel (wPac) and showed an objective response rate (ORR) of 23.7% (n=14), a median progression free survival (mPFS) of 4.0 months (95% confidence interval [CI] 3.0–6.1), and a median overall survival (mOS) of 10.2 months (95% CI 7.0–14.6). Among patients without liver involvement, patients receiving wPac (n=35) had significantly prolonged mPFS (5.8 vs. 3.2 months, respectively, p=0.014) with a tendency for prolonged mOS (13.8 vs. 11.6 months, respectively, p=0.13) than those receiving other regimens (n=12). A total of 24 patients received second- or later-line pazopanib monotherapy and showed an ORR of 16.7% (n=4), a mPFS of 2.4 months (95% CI 1.8–4.3) and a mOS of 5.4 months (95% CI 3.5–NA).
Conclusion
Treatment with first-line wPac and later-line pazopanib seems to provide survival benefit, especially for patients with advanced angiosarcoma without liver involvement.

Citations

Citations to this article as recorded by  
  • Punch Biopsy as a Diagnostic Keystone for Metastatic Cardiac Angiosarcoma Treated With Anthracycline-Based Chemotherapy: A Case Report
    Aonghus Joyce, Gráinne Murphy, Cynthia C Heffron, David Aherne, Richard M Bambury
    Cureus.2025;[Epub]     CrossRef
  • Clinicopathological features, treatment outcomes, and prognostic factors of angiosarcoma: a 21-year experience at one center
    Chenyan Fang, Xiaoting Zeng, Qing Ji, Tao Zhu, Meiyu Fang, Jun Cao
    Orphanet Journal of Rare Diseases.2025;[Epub]     CrossRef
  • Chest Wall Angiosarcoma with an Initial Presentation of Multiple Lung Metastases: a Case Report
    Hitoshi Suzuki, Mari Shinoda, Daisuke Ito, Shin Shomura, Kentaro Inoue, Kazuo Fukutome, Akira Shimamoto, Hisamichi Yuda
    Haigan.2024; 64(7): 917.     CrossRef
  • Hepatic Angiosarcoma with Peliosis Hepatis
    Kensuke Kitsugi, Kazuhito Kawata, Moe Matsumoto, Masahiro Umemura, Tomohiko Hanaoka, Maho Yamashita, Shingo Takatori, Jun Ito, Kazuyoshi Ohta, Takeshi Chida, Hidenao Noritake, Takafumi Suda
    Internal Medicine.2023; 62(8): 1157.     CrossRef
  • Conversion surgery for recurrent hepatic angiosarcoma after systemic chemotherapy with paclitaxel
    Yuta Ushida, Takafumi Sato, Tomotaka Kato, Yasuyuki Shigematsu, Hiromichi Ito, Takeshi Suzuki, Yosuke Inoue, Yoshihiro Ono, Atsushi Oba, Yu Takahashi
    Clinical Journal of Gastroenterology.2022; 15(2): 427.     CrossRef
  • Management of Cutaneous Angiosarcoma: an Update Review
    Siwei Bi, Ai Zhong, Xiya Yin, Jingyi Li, Ying Cen, Junjie Chen
    Current Treatment Options in Oncology.2022; 23(2): 137.     CrossRef
  • Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma
    Richard F Riedel, Victoria Chua, Ania Moradkhani, Natalie Krkyan, Amir Ahari, Atsushi Osada, Sant P Chawla
    The Oncologist.2022; 27(10): 809.     CrossRef
  • 9,189 View
  • 184 Download
  • 4 Web of Science
  • 7 Crossref
Close layer
Radiation-Induced Sarcoma: A 15-Year Experience in a Single Large Tertiary Referral Center
Kyung Su Kim, Ji Hyun Chang, Noorie Choi, Han-Soo Kim, Ilkyu Han, Kyung Chul Moon, Il Han Kim, Hak Jae Kim
Cancer Res Treat. 2016;48(2):650-657.   Published online September 9, 2015
DOI: https://doi.org/10.4143/crt.2015.171
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study is to report on the incidence and the experience in management of radiation-induced sarcoma (RIS) at a large single center in Korea for 15 years.
Materials and Methods
We retrospectively reviewed the sarcoma registry of a large institution from January 2000 to April 2014.
Results
Out of the 3,674 patients listed in the registry, 33 patients (0.9%) diagnosed with RIS were identified. The median latency of RIS was 12.1 years. The number of cases of RIS increased from four cases in the years 2000-2003 to 14 cases in the years 2012-2014. The most common histology was osteosarcoma (36.4%). The median follow-up period was 23.1 months, the median overall survival (OS) of all patients was 2.9 years, and their 5-year survival rate was 44.7%. Univariate and multivariate analyses showed association of the age at diagnosis (p=0.01) and the treatment aim (p=0.001) with the OS. The median OS and the 5-year survival rate of patients treated with curative surgery (n=19) were 9.6 years and 65%, respectively, and of the conservatively treated patients, 0.7 years and 0% (n=14). Re-irradiation was delivered to nine patients, and radiation toxicity was observed in five patients.
Conclusion
In this study, RIS accounted for 0.9% of the cases of sarcoma, with increasing incidence. Despite the association of curative resection with increased survival, it could be applied to only 58% of the patients. Considering the limited treatment options for RIS, conduct of a genetic study to identify the underlying mechanism of RIS is needed.

Citations

Citations to this article as recorded by  
  • Radiation-induced osteosarcoma in the head and neck region: Case report and literature review
    Iara Vieira Ferreira, Marcelo Elias Schempf Cattan, Carlos Takahiro Chone, Arthur Antolini, Erika Said Abu Egal, Albina Altemani, Fernanda Viviane Mariano
    Oral Oncology.2025; 162: 107216.     CrossRef
  • A bone tumor‐like chest wall mass lesion with pathological rib fractures observed 13 years after lung stereotactic body radiotherapy: A case report
    Masaki Matsuda, Jiro Ichikawa, Takafumi Komiyama, Kojiro Onohara, Masahide Saito, Hikaru Nemoto, Mizuki Kubota, Hiroshi Onishi
    Thoracic Cancer.2024; 15(26): 1912.     CrossRef
  • The role of perioperative treatment in radiation-associated soft tissue sarcomas
    Konrad Zasadziński, Mateusz Jacek Spałek
    Oncologie.2024; 26(6): 1065.     CrossRef
  • Clinical and Pathologic Characterization of 94 Radiation-Associated Sarcomas: Our Institutional Experience
    Erica Y. Kao, Abbye E. McEwen, James K. Aden, Stephanie K. Schaub, Robert W. Ricciotti, Jose G. Mantilla
    International Journal of Surgical Pathology.2023; 31(5): 532.     CrossRef
  • Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study
    Mauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, Ian Hirsch, Jay Wunder, Peter Ferguson, Kim Tsoi, Savtaj Brar, Rebecca Gladdy, Carol Swallow, Peter Chung, Charles Catton, Philip Wong, Geoffrey Watson, Albiruni Ryan Abdul Razak, Abha A. Gupta
    Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
  • Treatment and Outcomes of Radiation-Induced Soft Tissue Sarcomas of the Extremities and Trunk—A Systematic Review of the Literature
    Maria L. Inchaustegui, Kelly Kon-Liao, Kim Ruiz-Arellanos, George Aquilino E. Silva, Marcos R. Gonzalez, Juan Pretell-Mazzini
    Cancers.2023; 15(23): 5584.     CrossRef
  • Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas
    Andrea R. Daniel, Chang Su, Nerissa T. Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R. Selitsky, Jennifer L. Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M. Mowery, Diana M. Cardona, Cha
    Cancer Research Communications.2023; 3(12): 2455.     CrossRef
  • Treatment related factors associated with the risk of breast radio-induced-sarcoma
    Céline Mirjolet, Ibrahima Diallo, Aurélie Bertaut, Cristina Veres, Paul Sargos, Sylvie Helfre, Marie-Pierre Sunyach, Gilles Truc, Cécile Le Pechoux, Amaury Paumier, Anne Ducassou, Maria Jolnerovski, Juliette Thariat, Michel Lapeyre, Abel Cordoba, Marc-And
    Radiotherapy and Oncology.2022; 171: 14.     CrossRef
  • Radiation-induced osteosarcoma in the pubic bone after proton radiotherapy for prostate cancer: a case report
    Hiroatsu Nakashima, Tetsuro Takatsu, Reiko Imai
    Journal of Rural Medicine.2022; 17(2): 94.     CrossRef
  • Premalignant Conditions of Bone
    Michael D. Eckhoff, Matthew E. Wells, Osvaldo Padilla, Elizabeth M. Polfer, Christopher J. Castagno, Ahmed M. Thabet, Shaimaa Elzamly, Harry L. Wilson, Rajiv Rajani
    JAAOS: Global Research and Reviews.2022;[Epub]     CrossRef
  • Histology-Specific Prognostication for Radiation-Associated Soft Tissue Sarcoma
    Edmund K. Bartlett, Avinash Sharma, Kenneth Seier, Cristina R. Antonescu, Narasimhan P. Agaram, Bhumika Jadeja, Evan Rosenbaum, Ping Chi, Murray F. Brennan, Li-Xuan Qin, Kaled M. Alektiar, Samuel Singer
    JCO Precision Oncology.2022;[Epub]     CrossRef
  • Radiation-induced soft tissue sarcoma of the neck after radiation therapy for Hodgkin's lymphoma: a clinical case
    Nikolai A. Ognerubov, Tatiana S. Antipova
    Journal of Modern Oncology.2022; 24(3): 325.     CrossRef
  • Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels
    Libo Yang, Dongli Lu, Yutian Lai, Mengjia Shen, Qiuxiao Yu, Ting Lei, Tianjie Pu, Hong Bu
    Annals of Surgical Oncology.2021; 28(2): 975.     CrossRef
  • Radiation-Induced Sarcomas of the Head and Neck: A Systematic Review
    Andrés Coca-Pelaz, Antti A. Mäkitie, Primož Strojan, June Corry, Avraham Eisbruch, Jonathan J. Beitler, Sandra Nuyts, Robert Smee, Johannes A. Langendijk, William M. Mendenhall, Cesare Piazza, Alessandra Rinaldo, Alfio Ferlito
    Advances in Therapy.2021; 38(1): 90.     CrossRef
  • En bloc resection and reconstruction in patients with advanced recurrent nasopharyngeal carcinoma and radiation-induced sarcoma of the head and neck
    W.-l. Chen, Y.-M. Liu, B. Zhou, R. Chen, Z.-y. Lin, Z.-q. Huang, Z-x. Huang
    International Journal of Oral and Maxillofacial Surgery.2021; 50(6): 711.     CrossRef
  • Incidence of radiation induced sarcoma attributable to radiotherapy in adults: A retrospective cohort study in the SEER cancer registries across 17 primary tumor sites
    Anson Snow, Alexander Ring, Lucas Struycken, Wendy Mack, Melissa Koç, Julie E. Lang
    Cancer Epidemiology.2021; 70: 101857.     CrossRef
  • Radiation-Induced Sarcoma: A Retrospective Population-Based Study Over 34 Years in a Single Institution
    L.B. Callesen, A. Safwat, H.K. Rose, F.B. Sørensen, T. Baad-Hansen, N. Aggerholm-Pedersen
    Clinical Oncology.2021; 33(5): e232.     CrossRef
  • Proliferating trichilemmal tumour of the eyelid in a 7-year-old girl
    Avery Bryan, Susan Kurian, Yan Li, Paige Bundrick
    BMJ Case Reports.2021; 14(2): e237476.     CrossRef
  • Treating radiation-induced sarcoma of the head and neck: A case report
    Yuka Takumi, Kazufumi Obata, Atsushi Kondo, Ryo Miyata, Ayaka Sasaki, Kenichi Takano
    Otolaryngology Case Reports.2021; 19: 100283.     CrossRef
  • Pelvic Radiation-Induced Sarcoma With Rhabdomyoblastic Differentiation Following Treatment of Cervical Cancer
    Shahd S Almohsen, Hala Alnuaim, Alaa A Salim, Haitham Arabi
    Cureus.2021;[Epub]     CrossRef
  • MYC expression has limited utility in the distinction of undifferentiated radiation‐associated sarcomas from sporadic sarcomas and sarcomatoid carcinoma
    Jeffrey K Mito, Xiaohua Qian, Vickie Y Jo, Leona A Doyle
    Histopathology.2020; 77(4): 667.     CrossRef
  • Sarcomas óseos secundarios
    J.-C. Mattei, A. Griffin, P. Ferguson, G. Venton, J. Wunder, A. Rochwerger
    EMC - Aparato Locomotor.2020; 53(4): 1.     CrossRef
  • Sarcomes osseux secondaires
    J.-C. Mattei, A. Griffin, P. Ferguson, G. Venton, J. Wunder, A. Rochwerger
    EMC - Appareil locomoteur.2020; 34(3): 1.     CrossRef
  • Radiation-Associated Sarcomas
    Jeffrey K. Mito, Devarati Mitra, Leona A. Doyle
    Surgical Pathology Clinics.2019; 12(1): 139.     CrossRef
  • A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas
    Jeffrey K. Mito, Devarati Mitra, Constance M. Barysauskas, Adrián Mariño-Enriquez, Elizabeth A. Morgan, Christopher D.M. Fletcher, Chandrajit P. Raut, Elizabeth H. Baldini, Leona A. Doyle
    International Journal of Radiation Oncology*Biology*Physics.2019; 104(2): 425.     CrossRef
  • Osteosarcoma of the jaw – experience at the Medical University Vienna and comparative study with international tumor registries
    Christina Eder-Czembirek, Doris Moser, Simone Holawe, Thomas Brodowicz, Jutta Ries, Irene Sulzbacher, Edgar Selzer
    Clinics.2019; 74: e701.     CrossRef
  • Multifocal superficial rapidly growing postirradiation sarcoma mimicking metastatic carcinoma
    Debasis Gochhait, Priyadarshini Dehuri, Vidhyalakshmi Rangarajan, Neelaiah Siddaraju
    Journal of Mid-life Health.2019; 10(2): 101.     CrossRef
  • Radiation-induced sarcoma in a cat following hypofractionated, palliative intent radiation therapy for large-cell lymphoma
    Matthew R Cook, Michael P Martinez, Joelle M Fenger, Noopur C Desai
    Journal of Feline Medicine and Surgery Open Reports.2019;[Epub]     CrossRef
  • Unique Case Report of a Meningeal Sarcoma Arising during Ongoing Treatment for Progressing Intraparenchymal Glioma
    Richard A. Peterson, Bhavani Kashyap, Pamala A. Pawloski, Anna C. Forsberg, Leah R. Hanson
    Case Reports in Oncological Medicine.2019; 2019: 1.     CrossRef
  • Radiation‐associated sarcoma after breast cancer in a nationwide population: Increasing risk of angiosarcoma
    Samuli H. Salminen, Mika M. Sampo, Tom O. Böhling, Laura Tuomikoski, Maija Tarkkanen, Carl P. Blomqvist
    Cancer Medicine.2018; 7(9): 4825.     CrossRef
  • Radiation-Associated Sarcoma of the Neck: Case Series and Systematic Review
    Lawrence Williams, Lyubov Tmanova, Wojciech K. Mydlarz, Brandi Page, Jeremy D. Richmon, Harry Quon, Nicole C. Schmitt
    Annals of Otology, Rhinology & Laryngology.2018; 127(10): 735.     CrossRef
  • Radiation‐associated neoplasia: clinical, pathological and genomic correlates
    Lynette M Sholl, Justine A Barletta, Jason L Hornick
    Histopathology.2017; 70(1): 70.     CrossRef
  • Magnetic Resonance Imaging of Soft Tissue Masses
    Aaron D. Fain, Francesca D. Beaman
    Seminars in Roentgenology.2017; 52(4): 227.     CrossRef
  • Characteristics of tumors that have developed in mice injected with syngenic irradiated mesenchymal stem cells of bone marrow
    E. Yu. Moskaleva, E. S. Zhorova, Yu. P. Semochkina, A. V. Rodina, O. V. Vysotskaya, A. I. Glukhov, A. A. Chukalova, G. A. Posypanova, V. P. Saprykin
    Cell and Tissue Biology.2017; 11(5): 381.     CrossRef
  • Case Report: Primary De Novo Sarcoma In Transplant Pancreas Allograft
    S. Nagaraju, S.J. Grethlein, S. Vaishnav, A.A. Sharfuddin, J.A. Powelson, J.A. Fridell
    Transplantation Proceedings.2017; 49(10): 2352.     CrossRef
  • Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
    Lie-Qiang Liao, Hong-Hong Yan, Jun-Hao Mai, Wei-Wei Liu, Hao Li, Zhu-Ming Guo, Zong-Yuan Zeng, Xue-Kui Liu
    Chinese Journal of Cancer.2016;[Epub]     CrossRef
  • 14,480 View
  • 198 Download
  • 29 Web of Science
  • 36 Crossref
Close layer
Case Report
A Case of Erdheim-Chester Disease with Asymptomatic Renal Involvement
Hyun Jung Lee, Kyoung Yul Lee, Dong-Yeop Shin, Yun Gyoo Lee, Se Youn Choi, Kyung Chul Moon, Il-Kyu Han, Tae Min Kim
Cancer Res Treat. 2012;44(2):146-150.   Published online June 30, 2012
DOI: https://doi.org/10.4143/crt.2012.44.2.146
AbstractAbstract PDFPubReaderePub
Erdheim-Chester disease is a rare non-Langerhans-cell histiocytosis involving bones and multiple organs. Its clinical course can vary, from an asymptomatic state to a fatal disease, with renal involvement being a common cause of death. A 41-year-old man presented with a 10-month history of bilateral lower limb pain. Left perirenal soft-tissue infiltration had been found incidentally two years earlier. No progression of the lesion or deterioration of renal function was observed for a period of two years. At admission, plain radiography and magnetic resonance imaging of the patient's lower limbs showed patchy osteosclerosis. Biopsy of the tibia revealed histiocytic infiltration, which was found to be positive for CD68 and negative for CD1a. This report describes an unusual case of Erdheim-Chester disease involving a stationary course of disease with no specific treatment for a long period of time.

Citations

Citations to this article as recorded by  
  • Radiological assessment of extremity bone involvement in Erdheim-Chester disease: a systematic review of case reports
    Arash Azhideh, Alireza Pouramini, Sara Haseli, Elahe Abbaspour, Gita Karande, Fatemeh Kafi, Majid Chalian
    Skeletal Radiology.2025; 54(7): 1441.     CrossRef
  • Erdheim–Chester Disease Involving the Biliary System and Mimicking Immunoglobulin G4-Related Disease: A Case Report
    Hyuk Gi Hong, Yong Eun Chung, June Park, Yeo Eun Kim
    Journal of the Korean Society of Radiology.2023; 84(3): 757.     CrossRef
  • The role of nuclear medicine in the diagnosis of Erdheim–chester disease. A series of clinical observations
    A. S. Krylov, A. D. Ryzhkov, A. A. Odzharova, Ya. A. Shchipakhina, E. E. Stanyakina, A. A. Martinovich, K. D. Ilkaev, A. M. Stroganova, S. L. Dranko, O. P. Bliznyukovv, A. V. Kuzin, P. A. Zeynalova, A. A. Semenova, M. B. Dolgushin
    Oncohematology.2020; 15(1): 28.     CrossRef
  • Erdheim–Chester disease. Literature review and clinical case
    A. S. Krylov, M. B. Dolgushin, A. D. Ryzhkov, A. A. Odzharova, Ya. A. Shchipakhina, E. A. Sushentsov, O. P. Bliznyukov, S. M. Kaspshik, A. A. Martinovich, A. M. Stroganova, S. L. Dranko, P. A. Zeynalova, T. T. Valiev
    Oncohematology.2020; 15(2): 61.     CrossRef
  • Magnetic Resonance Imaging of Perirenal Pathology
    James F. Glockner, Christine U. Lee
    Canadian Association of Radiologists Journal.2016; 67(2): 149.     CrossRef
  • Erdheim-Chester Disease with Perirenal Masses Containing Macroscopic Fat Tissue
    Jonghyun Byeon, Kyung Ah Kim, Seong Su Hwang, Soo Youn Park, Hyun A Kim
    Journal of the Korean Society of Radiology.2015; 72(2): 143.     CrossRef
  • Urologic Manifestations of Erdheim-Chester Disease
    Daniel A. Yelfimov, Deborah J. Lightner, Matthew K. Tollefson
    Urology.2014; 84(1): 218.     CrossRef
  • Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series
    Roei D Mazor, Mirra Manevich-Mazor, Anat Kesler, Orna Aizenstein, Iris Eshed, Ronald Jaffe, Yakov Pessach, Ilan Goldberg, Eli Sprecher, Iris Yaish, Alexander Gural, Chezi Ganzel, Yehuda Shoenfeld
    BMC Medicine.2014;[Epub]     CrossRef
  • A Rare Cause of Late-Onset Cerebellar Ataxia: Erdheim–Chester Disease
    Senthilkumar V. Shanmugam, Madhan Kolappan, Mamta Garg, Winston J. Rennie, Peter Furness, Yusuf A. Rajabally
    The Cerebellum.2013; 12(4): 593.     CrossRef
  • Reply to Commentary on "A Case of Erdheim-Chester Disease with Asymptomatic Renal Involvement"
    Hyun Jung Lee, Tae Min Kim
    Cancer Research and Treatment.2012; 44(4): 280.     CrossRef
  • Commentary on "A Case of Erdheim-Chester Disease with Asymptomatic Renal Involvement"
    Gioacchino Li Cavoli
    Cancer Research and Treatment.2012; 44(4): 279.     CrossRef
  • 15,834 View
  • 78 Download
  • 11 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP